West Pharmaceutical Services, Inc.
WST
$263.51
-$15.59-5.59%
NYSE
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -7.09% | -17.85% | -16.97% | -10.69% | 1.20% |
| Total Depreciation and Amortization | 11.09% | 13.09% | 13.18% | 13.66% | 15.40% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -85.46% | -100.00% | -96.37% | 481.01% | -0.20% |
| Change in Net Operating Assets | -37.82% | 558.54% | 114.22% | -90.79% | 173.68% |
| Cash from Operations | -10.06% | -12.16% | -15.85% | -8.57% | 6.42% |
| Capital Expenditure | 15.84% | 3.45% | -4.14% | -9.36% | -27.43% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 30.00% | 74.63% | 74.63% | 70.77% | 87.34% |
| Cash from Investing | 15.87% | 4.72% | -2.71% | -7.89% | -24.58% |
| Total Debt Issued | 270.57% | -- | -- | -- | -- |
| Total Debt Repaid | -121.89% | -7,572.00% | -7,912.50% | -8,286.96% | -36.12% |
| Issuance of Common Stock | -60.30% | -61.33% | -35.88% | -38.30% | 14.88% |
| Repurchase of Common Stock | 63.37% | 34.02% | -25.58% | -151.40% | -143.07% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -3.44% | -3.47% | -3.68% | -4.09% | -4.12% |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 57.89% | 24.41% | -35.47% | -165.81% | -110.86% |
| Foreign Exchange rate Adjustments | 401.96% | 2.33% | -287.72% | -55.74% | -123.83% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 118.14% | 30.54% | -814.11% | -340.39% | -550.00% |